Status: Not yet recruiting
Pembrolizumab Concurrent With and Following Carbon-ion Radiotherapy for Locally Advanced Cervical Adenocarcinoma
The goal of this clinical trial is to learn if pembrolizumab works for cervical adenocarcinoma treat with concurrent chemo-carbon-ion radiaotherapy (CIRT). The main questions it aims to answer are: • Does concurrent chemo-CIRT with pembrolizumab improves 2-year progression-free survival (PFS), compared with concurrent chemoradiotherapy with conventional X-rays?
Participants needed: 45
Trial details
Phase: Phase 2Age: 18+Biological sex: FemaleType: InterventionalSponsor: Gunma UniversityUpdated: Feb 3, 2025Locations: 1
Eligibility criteria
1. Female participants who are at least 18 years of age on the day of signing in... [+1]
1. Has received prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2 agent...